SIREN : 890118458
LAZEO MEDICAL VERSAILLES is a French company founded 5 years ago, specialized in the sector Soins de beauté. Based in VERSAILLES (78000), this company of category ETI shows in 2023 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | N/C | 1 391 909 € | 1 666 319 € | 1 146 215 € |
| Net income | -82 463 € | 181 770 € | 440 746 € | 220 058 € |
| EBITDA | N/C | 227 222 € | 609 745 € | 335 124 € |
| Net margin | N/C | 13.1% | 26.5% | 19.2% |
In 2024, LAZEO MEDICAL VERSAILLES records a net loss of 82 k€. This deficit will reduce equity on the balance sheet.
-82 463 €
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 48%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
0.005%
48.122%
51.6%
In 2024, the debt ratio of LAZEO MEDICAL VERSAILLES (0.01) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of LAZEO MEDICAL VERSAILLES (48.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2023, the repayment capacity of LAZEO MEDICAL VERSAILLES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 174.35. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
174.347
In 2024, the liquidity ratio of LAZEO MEDICAL VERSAILLES (174.35) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2023, the interest coverage of LAZEO MEDICAL VERSAILLES (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Compare LAZEO MEDICAL VERSAILLES with other companies in the same sector:
The revenue of LAZEO MEDICAL VERSAILLES in 2023 is 1.4 M€.
LAZEO MEDICAL VERSAILLES recorded a net loss in 2024.
The headquarters of LAZEO MEDICAL VERSAILLES is located in VERSAILLES (78000), in the department Yvelines.
The tax return of LAZEO MEDICAL VERSAILLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LAZEO MEDICAL VERSAILLES operates in the sector Soins de beauté (NAF code 96.02B). See the 'Sector positioning' section above to compare the company with its competitors.